Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT06036485

Efficacy of Kerecis Omega 3 in Comparison to Clinical Standard Procedures

Efficacy of Kerecis Omega 3 Versus Standard of Care in Patients With Chronic Leg Ulcerations - a Randomized Trial With a New In-wound Split Design Approach

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Chronic leg ulcerations are a great burden for patients and the medical system alike. Frequent outpatient consultations with associated treatment costs and travel costs for the patient as well as psychosocial burdens remain an unmet problem in chronic wound care. There is an increasing need for definitive treatment of especially chronic venous and multifactorial chronic leg ulceration where arterial intervention is not a treatment option. Minimal invasive surgical interventions that do not require skin grafting can be performed under local anesthesia in an outpatient setting even in multimorbid patients. Kerecis Omega3 Wound is intact decellularized fish skin. The fish skin sheets contain fat, protein, elastin, glycans and other natural skin elements and it can be an effective treatment option in chronic leg ulcerations and is licensed for this use as a medical product in Switzerland. However, limited data without inter-wound bias is available for the use of Kerecis Omega 3 in chronic leg ulcerations. In this study the investigators propose to investigate the efficacy of Kerecis Omega 3 according to objective wound surface measurements using standardized digital photographs in patients with chronic leg ulcerations. Efficacy will be evaluated against standard of care wound debridement.

Conditions

Interventions

TypeNameDescription
DEVICEKerecis Omega 3Decellularized intact fish skin developed for the management of chronic wounds
PROCEDURESurgical debridementSuperficial sharp surgical debridement technique

Timeline

Start date
2023-05-01
Primary completion
2023-05-01
Completion
2023-05-01
First posted
2023-09-14
Last updated
2024-12-06

Source: ClinicalTrials.gov record NCT06036485. Inclusion in this directory is not an endorsement.